In GC cells with p53 gene mutations, the p53 signaling pathway may be disrupted, resulting in abnormal vital activities such as cell proliferation and apoptosis, ultimately leading to differences in GADD45B and SERPINE1 expression levels between GC and normal gastric tissue samples [25]. This evidence concerns the gene TP53 and gastric cancer.